2020 Settlement Program Reaches 96% Enrollment of Additional Registered Eligible Patients

Stryker Orthopaedics and Court-appointed committees of attorneys representing Rejuvenate Modular Neck Hip Stem and ABG II Modular Neck Hip Stem plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations reached an agreement to compensate certain additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to September 9, 2020 and within 10 years of implantation. This follows 2014 and 2016 Settlement Programs in which over 95% of eligible patients enrolled. Under this new agreement, certain additional patients are now eligible to participate and may apply for compensation.

Stryker has informed the courts in the New Jersey Multicounty and Federal Multidistrict litigations that 96% of additional registered eligible patients have enrolled in the Settlement Program as set forth in the Settlement Agreement announced in September 2020. The Claims Processor has begun the review process and will notify eligible claimants and their attorneys regarding compensation payments, the exact timing and amount of which will depend on factors and circumstances specific to each claim. It is expected that a majority of the payments will be made by the end of 2021.

Please continue to visit this website, the official website for the Settlement Program, for important information and regular updates on the Settlement Program. You may also contact the Claims Processor with any questions by emailing claimsprocessor@StrykerModularHipSettlement.com or by calling the toll-free hotline at 1-855-382-6404.

Last Updated:  1/20/2021